{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:38:07Z","timestamp":1791214687280,"version":"4.1.0"},"reference-count":163,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8_suppl_5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[2002,4,23]]},"DOI":"10.1212\/wnl.58.8_suppl_5.s27","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T14:01:20Z","timestamp":1336917680000},"source":"Crossref","is-referenced-by-count":261,"title":["Depression and epilepsy"],"prefix":"10.1212","volume":"58","author":[{"given":"Andres M.","family":"Kanner","sequence":"first","affiliation":[{"name":"From the Department of Neurological Sciences, Rush Medical College, Rush Epilepsy Center, Rush-Presbyterian St. Luke\u2019s Medical Center, Chicago, IL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoaneta","family":"Balabanov","sequence":"additional","affiliation":[{"name":"From the Department of Neurological Sciences, Rush Medical College, Rush Epilepsy Center, Rush-Presbyterian St. Luke\u2019s Medical Center, Chicago, IL."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1986.00520080014012"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1987.tb03659.x"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.140.3.236"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1982.04290010080014"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1975.tb04721.x"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1006\/ebeh.2000.0050"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.53.1.3"},{"key":"e_1_3_1_9_2","first-page":"175.","volume":"41","year":"2000","unstructured":"Viikinsalo M, Sawrie S, Kuzniecky RI, Faught ER, Martin RC, Gilliam F. Depression and medication toxicity, but not seizure frequency or severity, predict health outcomes in refractory epilepsy. Epilepsia . 2000; 41 (suppl 7): 175.","journal-title":"Epilepsia"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700056403"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1987.tb05616.x"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-3182(81)73498-4"},{"key":"e_1_3_1_13_2","unstructured":"Betts   T.   Depression anxiety and epilepsy.  In:  Reynolds  E Trimble  M eds.  Epilepsy and psychiatry.   New York:   Churchill Livingstone 1981:  60\u201366."},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/94.1.173"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6974(88)80119-1"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1996.tb00006.x"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.epirev.a036182"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.80.328.1"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0920-1211(90)90010-S"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(200002)47:2<246::AID-ANA17>3.0.CO;2-E"},{"key":"e_1_3_1_21_2","first-page":"222A.","volume":"39","year":"1998","unstructured":"Hesdorffer DC, Ludvigsson P, Hauser WA, Olafsson E. Depression is a risk factor for epilepsy in children [Abstract]. Epilepsia . 1998; 39: 222A.","journal-title":"Epilepsia"},{"key":"e_1_3_1_22_2","unstructured":"Hauser   WA Hesdorffer   DC.   Psychosis depression and epilepsy: epidemiologic considerations.  In:  Ettinger  AB Kanno  AM eds.  Psychiatric issues in epilepsy: a practical guide to diagnosis and treatment.   Baltimore:   Lippincott Williams & Wilkins 2000:  7\u201317."},{"key":"e_1_3_1_23_2","unstructured":"Ronald   S Duman   R.   The neurochemistry of mood disorders: preclinical studies.  In:  Charney  DS Nesler  EJ Bunney  BS eds.  Neurobiology of mental illnesses.   New York:   Oxford University Press 1999:  333\u2013348."},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.122.5.509"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevNeurobiol.v13.i4.10"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0893-133X(95)00072-L"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.130.6.695"},{"key":"e_1_3_1_28_2","unstructured":"Duman   RS Nestler   EJ.   Signal transduction pathways for catecholamine receptors.  In:  Bloom  FE Kupfer  DJ eds.  Psychopharmacology: the fourth generation of progress.   New York:   Raven Press 1995:  303\u2013320."},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(84)90100-X"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1989.01810010047007"},{"key":"e_1_3_1_31_2","first-page":"472","volume":"50","year":"1972","unstructured":"Murphy DL. L-Dopa, behavioral activation and psychopathology. Res Publ Assoc Res Nerv Ment Dis . 1972; 50: 472\u2013493.","journal-title":"Res Publ Assoc Res Nerv Ment Dis"},{"key":"e_1_3_1_32_2","first-page":"323","volume":"16","year":"1988","unstructured":"Jacob D, Silverstone T. Dextroamphetamine arousal in human subjects as a model for mania. Psychol Med . 1988; 16: 323\u2013329.","journal-title":"Psychol Med"},{"key":"e_1_3_1_33_2","unstructured":"Wilner   P.   Dopaminergic mechanisms in depression and mania.  In:  Bloom  FE Kupfer  DJ eds.  Psychopharmacology: the fourth generation of progress.   New York:   Raven Press 1995:  921\u2013931."},{"key":"e_1_3_1_34_2","unstructured":"Maes   M Meltzer   HY.   The serotonin hypothesis of major depression.  In:  Bloom  FE Kupfer  DJ eds.  Psychopharmacology: the fourth generation of progress.   New York:   Raven Press 1995:  933\u2013944."},{"key":"e_1_3_1_35_2","unstructured":"Garlow   SJ Musselman   DL Nemeroff   CB.   The neurochemistry of the mood disorders.  In:  Charney  DS Nesler  EJ Bunney  BS eds.  Neurobiology of mental illness.   New York:   Oxford University Press 1999:  348\u2013365."},{"key":"e_1_3_1_36_2","first-page":"4","volume":"52","year":"1991","unstructured":"Richelson E. Biological basis of depression and therapeutic relevance. J Clin Psychiatry . 1991; 52: 4\u201310.","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.138.3.252"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(98)00241-0"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1007\/PL00005185"},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1996.66041468.x"},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02229080"},{"key":"e_1_3_1_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(67)90190-7"},{"key":"e_1_3_1_43_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00432547"},{"key":"e_1_3_1_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(79)90124-2"},{"key":"e_1_3_1_45_2","first-page":"293.","volume":"144","year":"1963","unstructured":"Piette Y, Delaunois AL, De Shaepdryver AF, Heymans C. Imipramine and electroshock threshold. Arch Int Pharmacodyn Ther . 1963; 144: 293.","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"e_1_3_1_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(80)90430-X"},{"key":"e_1_3_1_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(97)00288-7"},{"key":"e_1_3_1_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(98)00580-9"},{"key":"e_1_3_1_49_2","unstructured":"Lewis JJ. Rauwolfia derivates. In: Root WS Hofmann G eds. Physiological pharmacology. New York: Academic Press 1974:79."},{"key":"e_1_3_1_50_2","unstructured":"Maynert   EW Marczynski   TJ Browning   RA.   The role of the neurotransmitters in the epilepsies.  In:  Friedlander  WJ ed.  Advances in neurology. Vol. 13. New York:   Raven Press 1975:  79\u2013147."},{"key":"e_1_3_1_51_2","doi-asserted-by":"crossref","unstructured":"Naidoo   D.   The effects of reserpine (serpasil) on the chronic disturbed schizophrenic: a comparative study of rauwolfia alkaloids and electroconvulsive therapy.   J Nerv Ment Dis   1956;  123.","DOI":"10.1097\/00005053-195601000-00001"},{"key":"e_1_3_1_52_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1955.02960010013003"},{"key":"e_1_3_1_53_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1955.tb42457.x"},{"key":"e_1_3_1_54_2","first-page":"104.","volume":"1","year":"1959","unstructured":"Berg S, Gabriel AR, Impastato DJ. Comparative evaluation of the safety of chlorpromazine and reserpine used in conjuction with ECT. J Neuropsychiatry . 1959; 1: 104.","journal-title":"J Neuropsychiatry"},{"key":"e_1_3_1_55_2","first-page":"282.","volume":"12","year":"1971","unstructured":"Fromm GH, Rosen JA, Amores CY. Clinical and experimental investigation of the effect of imipramine on epilepsy. Epilepsia . 1971; 12: 282.","journal-title":"Epilepsia"},{"key":"e_1_3_1_56_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.28.9.953"},{"key":"e_1_3_1_57_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1972.00490150006002"},{"key":"e_1_3_1_58_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.33.5.646"},{"key":"e_1_3_1_59_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.45.10.1926"},{"key":"e_1_3_1_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/0920-1211(95)00035-9"},{"key":"e_1_3_1_61_2","first-page":"2424.","volume":"23","year":"1997","unstructured":"Browning RA, Clark KB, Naritoku DK, Smith DC, Jensen RA. Loss of anticonvulsant effect of vagus nerve stimulation in the pentylenetetrazol seizure model following treatment with 6-hydroxydopamine or 5,7-dihydroxy-tryptamine [Abstract]. Proc Soc Neurosci . 1997; 23: 2424.","journal-title":"Proc Soc Neurosci"},{"key":"e_1_3_1_62_2","first-page":"23","volume":"2","year":"1987","unstructured":"Robertson M. Carbamazepine and depression. Int J Clin Psychopharmacol . 1987; 2: 23\u201335.","journal-title":"Int J Clin Psychopharmacol"},{"key":"e_1_3_1_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/0920-1211(92)90090-G"},{"key":"e_1_3_1_64_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1994.00540140061016"},{"key":"e_1_3_1_65_2","unstructured":"Blumer   D.   Epilepsy and disorders of mood.  In:  Smith  D Treiman  D Trimble  M eds.  Neurobehavioral problems in epilepsy.   New York:   Raven Press 1991;  185\u2013196."},{"key":"e_1_3_1_66_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1041220"},{"key":"e_1_3_1_67_2","doi-asserted-by":"publisher","DOI":"10.1177\/070674377902400613"},{"key":"e_1_3_1_68_2","unstructured":"Altshuler   L.   Depression and epilepsy.  In:  Devinsky  O Theodore  W eds.  Epilepsy and behavior.   New York Wiley-Liss 1991;  47\u201366."},{"key":"e_1_3_1_69_2","first-page":";27","year":"1986","unstructured":"Dodrill C, Batzel L. Interictal behavioral features of patients with epilepsy. Epilepsia . 1986 (suppl 2) ;27","journal-title":"Epilepsia"},{"key":"e_1_3_1_70_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.61.6.601"},{"key":"e_1_3_1_71_2","doi-asserted-by":"publisher","DOI":"10.1176\/jnp.8.3.287"},{"key":"e_1_3_1_72_2","doi-asserted-by":"publisher","DOI":"10.1080\/01616412.1993.11740124"},{"key":"e_1_3_1_73_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1990.00530030050016"},{"key":"e_1_3_1_74_2","unstructured":"Stevens   J.   Interictal clinical manifestations of complex partial seizures.  In:  Penry  J Daly  D eds.  Complex partial seizures and their treatment. Advances in Neurology. Vol. 11. New York:   Raven Press 1975:  85\u2013112."},{"key":"e_1_3_1_75_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1992.00530300049010"},{"key":"e_1_3_1_76_2","doi-asserted-by":"publisher","DOI":"10.1006\/ebeh.2000.0030"},{"key":"e_1_3_1_77_2","unstructured":"Seidenberg   M Hermann   BP Noe   A.   Depression in temporal lobe epilepsy: a possible role for associated frontal lobe dysfunction?  In:  Sackellares  JC Berent  S eds.  Psychological disturbances in epilepsy.   Newton MA:   Butterworth-Heinemann 1996;  143\u2013157."},{"key":"e_1_3_1_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(87)90047-3"},{"key":"e_1_3_1_79_2","doi-asserted-by":"publisher","DOI":"10.1080\/01688638808408253"},{"key":"e_1_3_1_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(91)90157-H"},{"key":"e_1_3_1_81_2","doi-asserted-by":"publisher","DOI":"10.1080\/01688639508402430"},{"key":"e_1_3_1_82_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1997.00550160019010"},{"key":"e_1_3_1_83_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-9452(13)80182-7"},{"key":"e_1_3_1_84_2","doi-asserted-by":"publisher","DOI":"10.1080\/01688639608408285"},{"key":"e_1_3_1_85_2","first-page":"119.","volume":"37","year":"1996","unstructured":"Hempel A, Risse GL, Mercer K, Gates J. Neuropsychological evidence of frontal lobe dysfunction in patients with temporal lobe epilepsy. Epilepsia . 1996; 37 (suppl 5): 119.","journal-title":"Epilepsia"},{"key":"e_1_3_1_86_2","first-page":"t","volume":"120","year":"1997","unstructured":"Jokeit H, Seitz RJ, Markowitsch HJ, Neumann N, Witte OW, Ebner A. Prefrontal asymmetric interictal glucose hypometabolism and cognitive impairment in patients with temporal lobe epilepsy. Brain . 1997; 120 (p t","journal-title":"Brain"},{"key":"e_1_3_1_87_2","first-page":"327","volume":"98","year":"1998","unstructured":"Menzel C, Grunwald F, Klemm E, Ruhlmann J, Elger CE, Biersack HJ. Inhibitory effects of mesial temporal partial seizures onto frontal neocortical structures. Acta Neurol Belg . 1998; 98: 327\u2013331.","journal-title":"Acta Neurol Belg"},{"key":"e_1_3_1_88_2","unstructured":"Blumer   D Altshuler   LL.   Affective disorders.  In:  Engel  J Pedley  TA eds.  Epilepsy: a comprehensive textbook. Vol. II. Philadelphia:   Lippincott-Raven 1998:  2083\u20132099."},{"key":"e_1_3_1_89_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1987.01800150017003"},{"key":"e_1_3_1_90_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1989.01810030049007"},{"key":"e_1_3_1_91_2","unstructured":"Starkstein   SE Robinson   RG.   Depression and frontal lobe disorders.  In:  Miller  BL Cummings  JL eds.  The human frontal lobes functions and disorders. Vol. 3 \u201326.  New York:   Gilford Press 1998:  537\u2013546."},{"key":"e_1_3_1_92_2","first-page":"54.","volume":"41","year":"2000","unstructured":"Gilliam F, Maton B, Martin RC, et al. Extent of 1H spectroscopy abnormalities independently predicts mood status and quality of life in temporal lobe epilepsy. Epilepsia . 2000; 41 (suppl 7): 54.","journal-title":"Epilepsia"},{"key":"e_1_3_1_93_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1986.tb03549.x"},{"key":"e_1_3_1_94_2","unstructured":"McConnell   H Duncan   D.   Treatment of psychiatric comorbidity in epilepsy.  In:  McConnell  H Snyder  P eds.  Psychiatric Comorbidity in epilepsy.   Washington:   American Psychiatric Press 1998:  245\u2013361."},{"key":"e_1_3_1_95_2","first-page":"909","volume":"80","year":"1987","unstructured":"Brent D, Crumrine P, Varma R. Phenobarbital treatment and major depressive disorder in children with epilepsy. Pediatrics . 1987; 80: 909\u2013917.","journal-title":"Pediatrics"},{"key":"e_1_3_1_96_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.140.1.112"},{"key":"e_1_3_1_97_2","first-page":"598","volume":"28","year":"1987","unstructured":"Smith D, Collins J. Behavioral effects of carbamazepine, phenobarbital, phenytoin and primidone. Epilepsia . 1987; 28: 598\u2013606.","journal-title":"Epilepsia"},{"key":"e_1_3_1_98_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.82.2.284"},{"key":"e_1_3_1_99_2","first-page":"970.","volume":"335","year":"1990","unstructured":"Ring H, Reynolds E. Vigabatrin and behavior disturbance. Lancet . 1990; 335: 970.","journal-title":"Lancet"},{"key":"e_1_3_1_100_2","first-page":"323.","volume":"6","year":"1994","unstructured":"McConnell H, Duffy J, Cress K. Behavioral effects of felbamate. J Neuropsychiatry Clin Neurosci . 1994; 6: 323.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"e_1_3_1_101_2","first-page":"169.","volume":"41","year":"2000","unstructured":"Kanner AM, Faught E, French J, et al. Psychiatric adverse events caused by topiramate and lamotrigine: a postmarketing prevalence and risk factor study [Abstract]. Epilepsia . 2000; 41 (suppl 7): 169.","journal-title":"Epilepsia"},{"key":"e_1_3_1_102_2","unstructured":"Savard   G Andermann   LF Reutens   D Andermann   F.   Epilepsy surgical treatment and postoperative psychiatric complications: a re-evaluation of the evidence.  In:  Trimble  MR Schmitz  B eds.  Forced normalization and alternative psychosis of epilepsy.   Petersfield:   Writson Biomedical Publishing 1998:  179\u2013192."},{"key":"e_1_3_1_103_2","unstructured":"Robertson   M.   Forced normalization and the aetiology of depression in epilepsy.  In:  Trimble  MR Schmitz  B eds.  Forced normalization and alternative psychosis of epilepsy.   Petersfield:   Writson Biomedical Publishing 1998;  143\u2013168."},{"key":"e_1_3_1_104_2","doi-asserted-by":"publisher","DOI":"10.1159\/000110765"},{"key":"e_1_3_1_105_2","unstructured":"Dell   J.   Social dimension of epilepsy: stigma and response.  In:  Whitman  S Hermann  B eds.  Psychopathology in epilepsy: social dimensions.   New York:   Oxford University Press 1986:  185\u2013210."},{"key":"e_1_3_1_106_2","doi-asserted-by":"publisher","DOI":"10.1016\/0277-9536(94)90396-4"},{"key":"e_1_3_1_107_2","unstructured":"Scambler G. Sociological aspects of epilepsy. In: Hopkins A ed. Epilepsy. New York: Demos 1987:."},{"key":"e_1_3_1_108_2","doi-asserted-by":"publisher","DOI":"10.1207\/s15324834basp0103_4"},{"key":"e_1_3_1_109_2","doi-asserted-by":"publisher","DOI":"10.1016\/0896-6974(89)90003-0"},{"key":"e_1_3_1_110_2","unstructured":"Dodrill   C.   Neuropsychology.  In:  Laidlaw  J Richens  A Chadwick  D eds.  A textbook of epilepsy.   4th ed.   London:   Churchill Livingstone 1993:  282\u2013291."},{"key":"e_1_3_1_111_2","unstructured":"Craig   C Oxley   J.   Social aspects of epilepsy.  In:  Laidlaw  J Richens  A Oxley  J eds.  A textbook of epilepsy 3rd ed.   London:   Churchill Livingstone 1988:  513\u2013544."},{"key":"e_1_3_1_112_2","doi-asserted-by":"publisher","DOI":"10.1016\/0896-6974(90)90158-U"},{"key":"e_1_3_1_113_2","unstructured":"Mittan   R.   Fear of seizures.  In:  Whitman  S Hermann  B eds.  Psychopathology in epilepsy: social dimensions.   New York:   Oxford University Press 1986:  90\u2013121."},{"key":"e_1_3_1_114_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1994.tb01796.x"},{"key":"e_1_3_1_115_2","unstructured":"Brown   S Reynolds   E.   Cognitive impairment in epileptic patients.  In:  Reynolds  E Trimble  M.  eds.  Epilepsy and psychiatry.   Edinburgh:   Churchill Livingstone 1981:  147\u2013158."},{"key":"e_1_3_1_116_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1988.tb06326.x"},{"key":"e_1_3_1_117_2","unstructured":"Holsboer   F.   Animal models of mood disorders.  In:  Charney  DS Nesler  EJ Bunney  BS eds.  Neurobiology of Mental Illness.   New York:   Oxford University Press 1999;  317\u2013332."},{"key":"e_1_3_1_118_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-7634(05)80194-0"},{"key":"e_1_3_1_119_2","doi-asserted-by":"publisher","DOI":"10.1006\/ebeh.2001.0192"},{"key":"e_1_3_1_120_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/79.1.29"},{"key":"e_1_3_1_121_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-195506000-00002"},{"key":"e_1_3_1_122_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.115.2.97"},{"key":"e_1_3_1_123_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1952.03680030005003"},{"key":"e_1_3_1_124_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1959.03840010089011"},{"key":"e_1_3_1_125_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-198608000-00005"},{"key":"e_1_3_1_126_2","first-page":"A352.","volume":"54","year":"2000","unstructured":"Kanner AM, Soto A, Kanner-Gross HR. There is more to epilepsy than seizures: a reassessment of the postictal period [Abstract]. Neurology . 2000; 54: 7(suppl3): A352.","journal-title":"Neurology"},{"key":"e_1_3_1_127_2","unstructured":"Kanner   AM Kuzniecky   RI.   Psychiatric phenomena as an expression of postictal and paraictal events.  In:  Ettinger  AB Kanner  AM eds.  Psychiatric issues in epilepsy.   Baltimore:   Lippincott Williams & Wilkins 2000:  163\u2013180."},{"key":"e_1_3_1_128_2","first-page":"A147.","volume":"40","year":"1999","unstructured":"Kanner AM, Rabinovich A, Soto A, et al. The prevalence of postictal symptoms of depression in patients treated in tertiary epilepsy centers: a transcultural perspective [Abstract]. Epilepsia . 1999; 40 (suppl 2): A147.","journal-title":"Epilepsia"},{"key":"e_1_3_1_129_2","doi-asserted-by":"publisher","DOI":"10.2190\/7PD3-C5MM-M0GJ-WJWT"},{"key":"e_1_3_1_130_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1989.00520460041011"},{"key":"e_1_3_1_131_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-197110000-00007"},{"key":"e_1_3_1_132_2","first-page":"11","volume":"1","year":"1969","unstructured":"Anatassopoulos G, Kokkini D. Suicidal attempts in psychomotor epilepsy. Behav Neuropsychiatry . 1969; 1: 11\u201316.","journal-title":"Behav Neuropsychiatry"},{"key":"e_1_3_1_133_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-199307000-00007"},{"key":"e_1_3_1_134_2","doi-asserted-by":"publisher","DOI":"10.1176\/jnp.7.4.445"},{"key":"e_1_3_1_135_2","unstructured":"Kraepelin   E.   Psychiatrie. Vol. 3. Leipzig:   Johann Ambrosius Barth 1923."},{"key":"e_1_3_1_136_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2044-8260.1967.tb00530.x"},{"key":"e_1_3_1_137_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1961.01710120031004"},{"key":"e_1_3_1_138_2","unstructured":"Robertson   M.   Depression in patients with epilepsy: an overview and clinical study.  In:  Trimble  M ed.  The psychopharmacology of epilepsy.   New York:   John Wiley & Sons 1985:  65\u201383."},{"key":"e_1_3_1_139_2","first-page":"289","volume":"54","year":"1993","unstructured":"Rosenstein D, Nelson J, Jacobs S. Seizures associated with antidepressants: a review. J Clin Psychiatry . 1993; 54: 289\u2013299.","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_1_140_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.44.1.55"},{"key":"e_1_3_1_141_2","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.56.8.756"},{"key":"e_1_3_1_142_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v58n1202"},{"key":"e_1_3_1_143_2","first-page":"271","volume":"58","year":"1997","unstructured":"Fogelson DL, Sternbach H. Lamotrigine treatment of refractory bipolar disorder. J Clin Psychiatry . 1997; 58: 271\u2013273.","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_1_144_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199706000-00008"},{"key":"e_1_3_1_145_2","first-page":"160","volume":"53","year":"1992","unstructured":"Preskorn S, Fast G. Tricyclic antidepressant-induced seizures and plasma drug concentration. J Clin Psychiatry . 1992; 53: 160\u2013162.","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_1_146_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199818020-00004"},{"key":"e_1_3_1_147_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199501004-00003"},{"key":"e_1_3_1_148_2","first-page":"43","volume":"12","year":"1994","unstructured":"Spiller H, Ramoska E, Krenzelok E, et al. Bupropion overdose: a 3-year multicenter retrospective analysis. Am J Emerg Med . 1994; 12: 43\u201345.","journal-title":"Am J Emerg Med"},{"key":"e_1_3_1_149_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1991.98"},{"key":"e_1_3_1_150_2","first-page":"126.","volume":"51","year":"1990","unstructured":"Pearson H. Interaction of fluoxetine with carbamazepine. J Clin Psychiatry . 1990; 51: 126.","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_1_151_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1991.tb03200.x"},{"key":"e_1_3_1_152_2","first-page":"33","volume":"28","year":"1989","unstructured":"Schiwy W, Heath W, Delini-Stula A. Therapeutic and side-effect profile of a selective and reversible MAO-A inhibitor, brofaromine. Results of dose-finding trials in depressed patients. J Neural Transm . 1989; 28 (suppl): 33\u201344.","journal-title":"J Neural Transm"},{"key":"e_1_3_1_153_2","first-page":"35","volume":"16","year":"1991","unstructured":"Wolf ME, Caro M, Mosnaim MD. Lithium neuroleptic interactions: electroencephalographic studies. Res Commun Psychol Psychiatry Behav . 1991; 16 (1&2): 35\u201340.","journal-title":"Res Commun Psychol Psychiatry Behav"},{"key":"e_1_3_1_154_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.162.5.689"},{"key":"e_1_3_1_155_2","doi-asserted-by":"crossref","unstructured":"Post   R Putnam   F Uhde   T Weiss   SR.   Electroconvulsive therapy as an anticonvulsant: implications for its mechanisms of action in affective illness.  In:  Malitz  S Sackeim  H eds.  Electroconvulsive therapy: clinical and basic research issues.   New York:   New York Academy of Sciences 1986:  376\u2013388.","DOI":"10.1111\/j.1749-6632.1986.tb51272.x"},{"key":"e_1_3_1_156_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.43.12.1098"},{"key":"e_1_3_1_157_2","unstructured":"Abrams   R.   Electroconvulsive therapy in the high-risk patient.  In:  Abrams  R ed.  Electroconvulsive therapy.   New York:   Oxford University Press 1997:  81\u2013113."},{"key":"e_1_3_1_158_2","first-page":"5","volume":"15","year":"1999","unstructured":"Sackeim HA. The anticonvulsant hypothesis of the mechanisms of action of ECT: current status. ECT . 1999; 15: 5\u201326.","journal-title":"ECT"},{"key":"e_1_3_1_159_2","first-page":"39","volume":"8","year":"1992","unstructured":"Viparelli U, Viparelli G. ECT and grand mal epilepsy. Convulsive Ther . 1992; 8: 39\u201342.","journal-title":"Convulsive Ther"},{"key":"e_1_3_1_160_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(95)00053-J"},{"key":"e_1_3_1_161_2","first-page":"1301","volume":"18","year":"1983","unstructured":"Sackeim HA, Decina P, Prohovnik I, et al. Anticonvulsant and antidepressant properties of electroconvulsive therapy: a proposed mechanism of action. Biol Psychiatry . 1983; 18: 1301\u20131310.","journal-title":"Biol Psychiatry"},{"key":"e_1_3_1_162_2","doi-asserted-by":"publisher","DOI":"10.1097\/00019442-199805000-00012"},{"key":"e_1_3_1_163_2","first-page":"282","volume":"15","year":"1999","unstructured":"Fink M, Kellner C, Sackheim HA. Intractable seizures, status epilepticus and ECT. J ECT . 1999; 15: 282\u2013284.","journal-title":"J ECT"},{"key":"e_1_3_1_164_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1990.tb05498.x"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/full\/10.1212\/WNL.58.8_suppl_5.S27","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T16:02:39Z","timestamp":1711641759000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.58.8_suppl_5.S27"}},"subtitle":["How closely related are they?"],"short-title":[],"issued":{"date-parts":[[2002,4,23]]},"references-count":163,"journal-issue":{"issue":"8_suppl_5","published-print":{"date-parts":[[2002,4,23]]}},"alternative-id":["10.1212\/WNL.58.8_suppl_5.S27"],"URL":"https:\/\/doi.org\/10.1212\/wnl.58.8_suppl_5.s27","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,4,23]]}}}